Status:
RECRUITING
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
Lead Sponsor:
University of Miami
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Sleep Apnea
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended...
Eligibility Criteria
Inclusion
- Self-reported race/ethnicity as African American, African, Caribbean or black
- Ages 60-85 years
- accessible by phone
- OSA diagnosis
- consent, including permission to release medical data
Exclusion
- progressive illnesses in which disability or death is expected within 1 year
- impaired cognitive/ functional ability precluding participation
- intention to move within the year
- and a family member currently enrolled.
Key Trial Info
Start Date :
March 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2028
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT06089161
Start Date
March 19 2024
End Date
May 31 2028
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136